Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 3 recall · DMRC - 37371169
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution | PL: 20075/0692 | Ipratropium bromide | 05055565739587 |
Batches (expiry): UK25B06 (31/03/2028)
Background: Accord Healthcare Ltd is recalling the above batch after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. The incorrectly labelled ampoules are the same product and contain the same active ingredient but have Korean language labels and different batch details. Advice for Healthcare Professionals: Stop supplying the above batch immediately.